Company intelligence / Profile preview

Biotest AG

Dreieich, Hessen, Germanybiotest.com ↗
Ownership
Public · BIO
Employees
~2495
Development stage
Phase 3
01

Overview

Biotest AG develops and markets plasma protein products and biotherapeutic drugs. Its portfolio includes approved therapies for immune deficiencies and bleeding disorders. Recent milestones include FDA approval of Yimmugo for primary antibody deficiencies in 2024.

Therapeutic areas
OtherHematologyImmunology
Modalities
Plasma-derived proteins (immunoglobulins, clotting factors, albumin)monoclonal antibodies
Industry
Biotech
02

Drug pipeline

16 assets

polyvalent human immunoglobulin

Approved

15 more assets in the full pipeline.

Request access →
03

Partnerships

Kedrion Biopharma Inc. for U.S. commercialization/distribution of Yimmugo® [2024]Distribution partners worldwide across Europe/North America/South America/Asia/Middle East/Africa
04

Financials

Market cap
$10.2B
Total revenue
$651M
Enterprise value
$9.8B

Beyond the preview

Go deeper on Biotest AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotest AG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call